CT-guided transthoracic needle biopsy is a simple and safe procedure that has a diagnostic accuracy of 64–97 percent for pulmonary lesions (5-8). As a result, one of the most common approaches for diagnosing the nature of pulmonary lesions is to use this process. For precise treatment of advanced non-small-cell lung cancer, molecular investigation of driver mutations is strongly suggested (NSCLC)